Prospera Financial Services
NBIX icon

Prospera Financial Services’s Neurocrine Biosciences NBIX Stock Holding History

Prospera Financial Services’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$534K Buy
3,655
+2,226
+156% +$358K 0.01% 1045
2026
Q2 		$241K Buy
+1,429
New +$212K ﹤0.01% 1329
2026
Q1 		– Sell
-3,895
Closed -$552K – 1475
2025
Q4 		$552K Buy
3,895
+42
+1% +$6.08K 0.01% 890
2025
Q3 		$541K Buy
3,853
+18
+0.5% +$2.44K 0.01% 907
2025
Q2 		$482K Buy
3,835
+1,158
+43% +$133K 0.01% 920
2025
Q1 		$296K Buy
2,677
+86
+3% +$10.9K 0.01% 992
2024
Q4 		$354K Buy
2,591
+9
+0.3% +$1.11K 0.01% 867
2024
Q3 		$297K Sell
2,582
-24
-0.9% -$3.29K 0.01% 924
2024
Q2 		$359K Sell
2,606
-333
-11% -$45.7K 0.01% 842
2024
Q1 		$405K Buy
2,939
+100
+4% +$13.7K 0.01% 776
2023
Q4 		$374K Sell
2,839
-85
-3% -$9.8K 0.01% 754
2023
Q3 		$329K Sell
2,924
-73
-2% -$7.69K 0.01% 769
2023
Q2 		$283K Buy
+2,997
New +$293K 0.01% 823
2022
Q2 		– Sell
-496
Closed -$46K – 2248
2022
Q1 		$46K Buy
+496
New +$42K ﹤0.01% 1413
2021
Q3 		– Sell
-12,679
Closed -$1.23M – 834
2021
Q2 		$1.23M Buy
+12,679
New +$1.22M 0.06% 336
2020
Q4 		– Sell
-10
Closed -$1K – 1245
2020
Q3 		$1K Buy
+10
New +$1.16K ﹤0.01% 1557

Other funds holding NBIX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
IEQ Capital
IEQ Capital Foster City, California $23.5B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Prospera Financial Services's NBIX Position: Q3 2026 in Review

Prospera Financial Services increased its Neurocrine Biosciences (NBIX) stake by 156% in Q3 2026, buying an estimated $358K and bringing the position to 3,655 shares worth $534K. The position accounts for 0.01% of the portfolio, ranked #1045.

Prospera Financial Services first reported a position in NBIX in Q3 2020 and has held it in 16 quarters since. The position peaked at $1.23M in Q2 2021. 446 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • Prospera Financial Services held 3,655 shares of Neurocrine Biosciences worth $534K as of Q3 2026.
  • Prospera Financial Services bought 2,226 Neurocrine Biosciences shares in Q3 2026, an estimated $358K.
  • Neurocrine Biosciences made up 0.01% of Prospera Financial Services's portfolio in Q3 2026, its #1045 holding.
  • Prospera Financial Services first reported a position in Neurocrine Biosciences in Q3 2020 and has held it in 16 quarters since.
  • Prospera Financial Services's Neurocrine Biosciences position peaked at $1.23M in Q2 2021.
  • 446 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on Prospera Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.